Corporate

Position statement: Cessation of smoking products

Position statement: Cessation of smoking products

Smoking products are defined as tobacco cigarettes, cigars, and pipes, and e-cigarettes.
Our advocacy efforts in smoking products cessation focus on increased funding for, and access to, evidence-based services and products. We promote cessation support to the public and to our clients living with a lung disease and promote cessation support training to health professionals.

It is critical that smoking cessation efforts do not stigmatise individuals, including people living with a lung disease, who have a history of smoking. It is important to recognise that nicotine is a harmful and highly addictive drug for which patterns of use and the development of dependence are strongly influenced by structural factors (e.g. availability, price, social pressures, regulations). For many years the tobacco industry has profited off a known harmful and addictive substance. They are extremely well resourced and continue to launch new products and challenge effective tobacco control legislation.
The document provides Lung Foundation Australia’s recommendations for cessation efforts and gives an overview of the evidence for cessation methods, Australian cessation services and products, key cessation statistics, and enablers and barriers to cessation (noting that information on each of these aspects as they relate to e-cigarette cessation is limited due to the recency of e-cigarette use).

We advise that a combination of nicotine replacement therapy and oral nicotine medications accompanied by professional behavioural support is the most effective cessation method. There is currently insufficient peer-reviewed scientific evidence for the use of e-cigarettes for tobacco cigarette cessation.

Lung Foundation Australia’s recommendations:

  1. Seek innovative methods to provide supportive cessation advice
  2. Increase and sustain funding of Tackling Indigenous Smoking (TIS)
  3. Encourage healthcare professionals to complete evidence-based cessation training
  4. Make nicotine replacement therapy (NRT) and cessation medication free when it is provided through structured evidence-based cessation counselling
  5. Fund pilot programs to determine best practice nicotine cessation for young Australians

Was this page helpful?

Good job! Please give your positive feedback

How could we improve this post? Please Help us.

Last updated on June 23rd, 2025 at 05:32 pm

Menu

Welcome to our new website!

We’re still fine-tuning things, so thanks for your patience if you spot any issues. If you’d like to share your feedback, click the ‘Feedback’ button in the bottom right corner of the page. While we can’t action every suggestion, all ideas guide our future improvements.

Search

More

Search

Filter and sort

Article type

All articles
Category Article type

Lung disease

Select one or more
Lung disease Article

Topic

Select one or more
Category Article topic

Sort by

Filter and sort

Category

Select one or more
Category product

Sort by

Filter and sort

Lung disease

Select one or more
Category lung disease LFA services

Service type and category

Service delivery method

Select one or more
Service delivery method

Post code

Your current location

Sort by

Filter and sort

I am...

Select one or more
Category who resource

Lung disease

Select one or more
Category lung disease resource

Resource type

Select one or more
Category Resource type

Resource language

Select one or more
Category lang resource

Only certain resources will be available in alternative languages

Sort by

Filter and sort

Lung disease

Select one or more
Lung Disease research

Research category

Select one or more
Category research

Year

Select one or more
Year Research

Sort by

Filter and sort

Type

Select one or more
Post Type Filter

Sort by

Filter and sort

Lung disease

Select one or more
Category news

Sort by

Filter and sort

Topic

Select one or more
Category topic training

Type

Select one or more
Category type training

Sort by

Filter and sort

I am...

Select one or more
Category who events

Lung disease

Select one or more
Category lung disease events

Type

Select one or more
Category type events

Sort by